Abiopharma

Mandatory Warrant Exercise :

Mandatory Warrant Exercise :

Mandatory Warrant Exercise :

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Lim Wee Kian

Financial Statements and Related Announcement: Profit Guidance

General Announcement: Notice to Warrantholders - Expiry of Warrants on 29 June 2026

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Midnight Sun Continues Rapid Strike Expansion at Dumbwa; Now 6.7 Kilometres of Near-Surface Copper Mineralization

Collective Mining Discovers a New Tungsten Enriched High-Grade Subzone 300 Meters Below Surface at Apollo by Drilling 27.35 m at 37.55 g/t AuEq (1.68% WO3, 11.62 g/t Au, 54 g/t Ag, 0.43% Cu)